Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Glucose homeostasis can be differentially modulated by varying individual components of a western diet.

Forbes JM, Cowan SP, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, Cooper ME, Coughlan MT.

J Nutr Biochem. 2013 Jul;24(7):1251-7. doi: 10.1016/j.jnutbio.2012.09.009. Epub 2013 Jan 11.

PMID:
23313044
2.

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.

Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, Coughlan MT, Cooper ME, Nguyen TV, Ritchie RH, Forbes JM.

Free Radic Biol Med. 2012 Feb 1;52(3):716-723. doi: 10.1016/j.freeradbiomed.2011.11.017. Epub 2011 Nov 21.

PMID:
22172526
3.

Targeted reduction of advanced glycation improves renal function in obesity.

Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Courten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, de Courten B, Forbes JM.

Kidney Int. 2011 Jul;80(2):190-8. doi: 10.1038/ki.2011.57. Epub 2011 Mar 16.

4.

Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.

Sourris KC, Harcourt BE, Penfold SA, Yap FY, Morley AL, Morgan PE, Davies MJ, Baker ST, Jerums G, Forbes JM.

Exp Diabetes Res. 2010;2010:974681. doi: 10.1155/2010/974681. Epub 2011 Jan 5.

5.

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.

Sourris KC, Morley AL, Koitka A, Samuel P, Coughlan MT, Penfold SA, Thomas MC, Bierhaus A, Nawroth PP, Yamamoto H, Allen TJ, Walther T, Hussain T, Cooper ME, Forbes JM.

Diabetologia. 2010 Nov;53(11):2442-51. doi: 10.1007/s00125-010-1837-2. Epub 2010 Jul 15.

Supplemental Content

Loading ...
Support Center